首页 | 本学科首页   官方微博 | 高级检索  
     


Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome
Authors:BU Fitzky  M Witsch-Baumgartner  M Erdel  JN Lee  YK Paik  H Glossmann  G Utermann  FF Moebius
Affiliation:Institut für Biochemische Pharmakologie, Universit?t Innsbruck, Peter Mayr Strasse 1, A-6020 Innsbruck, Austria.
Abstract:The Smith-Lemli-Opitz syndrome (SLOS) is an inborn disorder of sterol metabolism with characteristic congenital malformations and dysmorphias. All patients suffer from mental retardation. Here we identify the SLOS gene as a Delta7-sterol reductase (DHCR7, EC 1.3.1. 21) required for the de novo biosynthesis of cholesterol. The human and murine genes were characterized and assigned to syntenic regions on chromosomes 11q13 and 7F5 by fluorescense in situ hybridization. Among the mutations found in patients with the SLOS, are missense (P51S, T93M, L99P, L157P, A247V, V326L, R352W, C380S, R404C, and G410S), nonsense (W151X), and splice site (IVS8-1G>C) mutations as well as an out of frame deletion (720-735 del). The missense mutations L99P, V326L, R352W, R404C, and G410S reduced heterologous protein expression by >90%. Our results strongly suggest that defects in the DHCR7 gene cause the SLOS.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号